|Prof. Kerstin Konrad|
|Prof. Beate Herpertz‐Dahlmann|
|Dr Timo Vloet|
Description of the organization
The University Hospital of the RWTH Aachen is one of the largest hospitals in Europe. The RWTH Aachen University has been awarded funding within the Excellence Initiative of the German Federal and State Governments since 2007. As a result of this funding, a formal structure for scientific collaboration between the RWTH and the Research Centre Jülich was established and called the “Jülich Aachen Research Alliance”. The alliance currently has three branches, one of which is the “Translational Brain Medicine” branch. The Department of Child and Adolescent Psychiatry (headed by Beate Herpertz‐Dahlmann) comprises a day clinic, an outpatient department and clinical wards for children and adolescents with diverse psychiatric disorders. The Child Neuropsychology Section (headed by Kerstin Konrad) specializes in innovative research into neurobiological mechanisms of developmental disorders as well as in clinical and neuropsychological assessments of children with neuropsychiatric disorders such as ADHD, Conduct Disorder, Schizophrenia and Autism Spectrum Disorders. The Department of Child and Adolescent Psychiatry deals with approximately 1800 new children and adolescents with ADHD per year (including both in‐ and outpatients). In addition, they have a database of more than 2500 children with ADHD including clinical, medication and neuropsychological data.
UKAACHEN (Kerstin Konrad) has been involved in many international collaborations and international research training groups. Neuroscientific research, including multi‐site national and international neuropsychological, genetic and neuroimaging trials in childhood neuropsychiatric disorders has been sponsored by the German Research Council (DFG KFO‐112‐II; IRTG 1328) and the Federal Ministry of Education and Science (BMBF‐EDNET‐01GV0602, BMBF‐MIRROR‐Neurons, BMBF‐ANAC‐01GJ0808). Kerstin Konrad has been the Principle Investigator of several large‐scale multi‐centre research projects, including a screening study for mathematics difficulties in young children and neuropsychological deficits associated with starvation in anorexia nervosa. She has been deputy speaker of the interdisciplinary clinical research group on attentional disorders (DFG KFO‐112‐II) and also leads several large‐scale medication and nutritional supplement studies in ADHD (Konrad et al 2004; 2005; 2006). UKAACHEN is also embedded in and benefits from an environment of cutting‐edge neuroscience with respect to infrastructure and expertise as evidenced by numerous high‐level publications and successful grant applications.
Profile of staff members
Kerstin Konrad (PhD) is a child neuropsychologist and Professor of Clinical Child Neuropsychology and Neuroimaging at the Department of Child and Adolescent Psychiatry. She has been involved in numerous studies with children and adolescents with ADHD, Conduct Disorder, Tourette Syndrome, Autism Spectrum Disorder and learning disabilities. Furthermore, she is active in genetic, brain imaging
and cognitive studies, and has published over 80 peer‐reviewed papers.
Beate Herpertz‐Dahlmann (MD) is Head of the Department of the Child and Adolescent Psychiatry and is involved in applied research in ADHD, Conduct Disorder, Autism and Eating Disorders.
Thomas Günther (PhD) is a neuropsychologist and speech pathologist. His areas of expertise include cognitive effects of medication in children, such as effects of methylphenidate, risperidone or sertraline.
Timo Vloet (MD) is Head of the children’s ward in the Department of Child and Adolescent Psychiatry and he is specialized in neurobiological research of Conduct disorder and ADHD.
Main tasks in the project
This partner is responsible for WP6 (adverse neurological effects). In addition, UKAACHEN will participate in WP2 and WP3.
The fifth ADDUCE Newsletter is now available!
Here, you can read about the finalisation of the project,
the European Medicines Agency and General Assembly meetings
and the dissemination of the results!
The fourth ADDUCE Newsletter is available!
In this newsletter, you can find some information on the final recruitment status of the 2 main studies:
- the prospective open-label methylphenidate pharmacovigilance study
- the long-term cardiascular effects of methylphenidate use
Also, you can read about the future plans of the project!
More than 1500 children, adolescents and adults across all Europe already took part in our study! Thanks to them, we have already gathered lots of information so we can know a lot more about methylphenidate than ever before!
Did you participate in the ADDUCE studies and are you curious about the latest news on the project?
Here you can find some information!
News for children, April 2015
News for adolescents, April 2015
News for parents, April 2015
The third ADDUCE Newsletter is available!
- the prospective open-label methylphenidate pharmacovigilance study: recruitment status and spin-
- the long-term cardiovascular effects of methylphenidate use: study design and participation
and much more in the ADDUCE Newsletter 3, March 2015
WP3: prospective open-label methylphenidate
- WP8: long-term cardiovascular effects of methylphenidate use
and much more in the ADDUCE Newsletter 2, February 2013
16 - 19 OCTOBER 2016:
4rd EUNETHYDIS International Conference on ADHD, Berlin - Germany
from basis neuroscience to optimised clinical care
17 & 18 APRIL 2016:
ADDUCE Consortium meeting, London - UK
28 - 31 MAY 2015:
5th World Congress on ADHD: from Child to Adult Disorder, Glasgow - Scotland
20 & 21 APRIL 2015:
ADDUCE Consortium meeting, Salina - Italy
21 - 24 MAY 2014:
3rd EUNETHYDIS International Conference on ADHD, Istanbul - Turkey
ADHD and related disorders
19 & 20 MAY 2014:
ADDUCE Consortium meeting, Istanbul - Turkey
3 - 6 OCTOBER 2013:
23rd EUNETHYDIS Network Meeting, Prague Czech Republic
A meeting of the European Network of Hyperkinetic Disorders
6 - 9 JUNE 2013:
4th World Congress on ADHD: from Childhood to Adult Disease, Milan - Italy
4 & 5 JUNE 2013:
ADDUCE Consortium meeting, Milan - Italy
6 & 7 JUNE 2012:
ADDUCE Consortium meeting, Cagliari - Italy
23 MAY 2012:
2nd EUNETHYDIS International Conference on ADHD, Barcelona - Spain